Infectious Disease Clinical Trials: Navigating Innovation & Rising Complexity

In a recent roundtable moderated by Citeline, industry experts, including one from Cerba Research, discussed the importance of incorporating evolving technological advances into existing infectious disease R&D workflows.

Tap into the key takeaways from this illuminating panel discussion in this informative roundtable summary.

Download the summary to learn more about:

Infectious disease’s evolving clinical landscape in the aftermath of COVID-19
Challenges in clinical research for infectious disease therapeutics
Barriers in infectious disease vaccine development
The future of infectious disease trials: surveillance, communication, regulatory, and AI

Download the Roundtable summary

Your Company Email Address

Opt In?

By completing this form You agree Citeline and Cerba Research may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and Cerba Research.